Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07509736

Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke

Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Beni-Suef University · Academic / Other
Sex
Female
Age
50 Years
Healthy volunteers
Not accepted

Summary

COPD represents an important public health challenge that is both preventable and treatable. GOLD is committed to improving the health of people at risk of and with COPD, wherever they happen to have been born, and wishes to do its bit to help achieve the United Nations Sustainable Development Goal to reduce premature mortality from non-communicable diseases - including COPD - by one third by 2030. GOLD aims in stable COPD to relieve symptoms, improve exercise tolerance and improve health status. Non-pharmacological interventions for those high-risk groups of patients, studies of intervention strategies both during inpatient stay and shortly after discharge have been undertaken, to decrease readmission rates and improve QOL, including disease-specific self-management, pulmonary rehabilitation, and early medical follow-up.Seeking for allow cost way to alleviate patients' symptoms in order to increase independence and QOL.

Detailed description

The study aimed to identify the effect of pulmonary rehabilitation on exercise tolerance, anxiety, depression, dyspnea and time to discharge from hospital in a group of COPD females admitted to inpatient wards till discharge from hospital.

Conditions

Interventions

TypeNameDescription
OTHERIntervention 1 → Arm 1 (pulmonary rehabilitation group).Arm1: pulmonary rehabilitation group participants will perform physical therapy program and receive standardized pulmonary rehabilitation. Intervention(s): pulmonary rehabiliation program

Timeline

Start date
2026-03-20
Primary completion
2026-06-10
Completion
2026-06-20
First posted
2026-04-03
Last updated
2026-04-03

Source: ClinicalTrials.gov record NCT07509736. Inclusion in this directory is not an endorsement.